Overview

BDD With UDCA Therapy After Laparoscopic Cholecystectomy

Status:
Unknown status

Trial end date:
2019-12-31

Target enrollment:

Participant gender:

Summary

Prospective Study for the Effects of Biphenyl Dimethyl Dicarboxylate and Ursodeoxycolic Acid Therapy on Liver Function and Quality of Life After Laparoscopic Cholecystectomy Primary endpoint: peak level of postoperative AST (aspartate transaminase) and postoperative ALT (alanine tansaminase) Secondary endpoint: postoperative GIQLI (Gastrointestinal Quality of Life index) score

Phase:

Phase 3

Details

Lead Sponsor:

Ewha Womans University Mokdong Hospital

Treatments:

7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester